Accustem Sciences Stock Performance
| ACUT Stock | USD 0.36 0.03 9.09% |
On a scale of 0 to 100, Accustem Sciences holds a performance score of 3. The firm shows a Beta (market volatility) of -0.85, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Accustem Sciences are expected to decrease at a much lower rate. During the bear market, Accustem Sciences is likely to outperform the market. Please check Accustem Sciences' coefficient of variation, semi variance, relative strength index, as well as the relationship between the treynor ratio and rate of daily change , to make a quick decision on whether Accustem Sciences' price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Accustem Sciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Accustem Sciences unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Accustem |
Accustem Sciences Relative Risk vs. Return Landscape
If you would invest 39.00 in Accustem Sciences on August 28, 2024 and sell it today you would lose (3.00) from holding Accustem Sciences or give up 7.69% of portfolio value over 90 days. Accustem Sciences is currently generating 0.4254% in daily expected returns and assumes 10.6554% risk (volatility on return distribution) over the 90 days horizon. In different words, 94% of otc stocks are less volatile than Accustem, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Accustem Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Accustem Sciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Accustem Sciences, and traders can use it to determine the average amount a Accustem Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0399
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ACUT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.66 actual daily | 94 94% of assets are less volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Accustem Sciences is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Accustem Sciences by adding it to a well-diversified portfolio.
Accustem Sciences Fundamentals Growth
Accustem OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Accustem Sciences, and Accustem Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Accustem OTC Stock performance.
About Accustem Sciences Performance
Assessing Accustem Sciences' fundamental ratios provides investors with valuable insights into Accustem Sciences' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Accustem Sciences is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive HER2- breast cancer and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. Accustem Sciences is traded on OTC Exchange in the United States.Things to note about Accustem Sciences performance evaluation
Checking the ongoing alerts about Accustem Sciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Accustem Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Accustem Sciences had very high historical volatility over the last 90 days | |
| Accustem Sciences has some characteristics of a very speculative penny stock | |
| About 45.0% of the company shares are held by company insiders |
- Analyzing Accustem Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Accustem Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Accustem Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Accustem Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Accustem Sciences' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Accustem Sciences' otc stock. These opinions can provide insight into Accustem Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Accustem OTC Stock Analysis
When running Accustem Sciences' price analysis, check to measure Accustem Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accustem Sciences is operating at the current time. Most of Accustem Sciences' value examination focuses on studying past and present price action to predict the probability of Accustem Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accustem Sciences' price. Additionally, you may evaluate how the addition of Accustem Sciences to your portfolios can decrease your overall portfolio volatility.